The circadian clock circuitry and the AHR signaling pathway in physiology and pathology

Biochemical Pharmacology

Volumn 85, Issue 10, 2013, Pages 1405-1416

  Anderson, George ^a   Beischlag, Timothy V ^b   Vinciguerra, Manlio ^c   Mazzoccoli, Gianluigi ^d  

^a Clinical Research Centre/Communications   (United Kingdom)

^b SIMON FRASER UNIVERSITY   (Canada)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

AHR; ARNT; Circadian rhythm; Clock gene

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; BINDING PROTEIN; CASEIN KINASE IDELTA; CASEIN KINASE IEPSILON; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; DAIDZEIN; DIOSMIN; EMODIN; GENISTEIN; GLUCURONOSYLTRANSFERASE 1A1; GLUTATHIONE S ARYLTRANSFERASE A1; GLYCOGEN SYNTHASE KINASE 3BETA; HEAT SHOCK PROTEIN 90; LANSOPRAZOLE; MESSENGER RNA; NARINGENIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OMEPRAZOLE; PER1 PROTEIN; PER2 PROTEIN; POLYCYCLIC AROMATIC HYDROCARBON; PRIMAQUINE; QUERCETIN; RESVERATROL; TOXIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; XENOBIOTIC AGENT;

ADAPTIVE IMMUNITY; ARTICLE; CIRCADIAN RHYTHM; DRUG METABOLISM; ENVIRONMENT; GENE EXPRESSION; GENE MUTATION; GENETIC POLYMORPHISM; HOMEOSTASIS; HUMAN; HYPOXIA; INFLAMMATION; LIGAND BINDING; METABOLISM; MOLECULAR INTERACTION; NONHUMAN; OSCILLATOR; OXIDATION; PATHOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UBIQUITINATION;

EID: 84876674991     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2013.02.022     Document Type: Note

References (150)

1. G. Mazzoccoli, V. Pazienza, and M. Vinciguerra Clock genes and clock-controlled genes in the regulation of metabolic rhythms Chronobiol Int 29 2012 227 251
2. S. Shimba, and Y. Watabe Crosstalk between the AHR signaling pathway and circadian rhythm Biochem Pharmacol 77 2009 560 565
3. M. Vinciguerra, M.P. Santini, C. Martinez, V. Pazienza, W.C. Claycomb, and A. Giuliani mIGF-1/JNK1/SirT1 signaling confers protection against oxidative stress in the heart Aging Cell 11 2012 139 149
4. G. Mazzoccoli, O. Palmieri, G. Corritore, T. Latiano, F. Bossa, and D. Scimeca Association study of a polymorphism in clock gene PERIOD3 and risk of inflammatory bowel disease Chronobiol Int 29 2012 994 1003
5. K. Bozek, A. Relogio, S.M. Kielbasa, M. Heine, C. Dame, and A. Kramer Regulation of clock-controlled genes in mammals PLoS ONE 4 2009 e4882
6. L. Stejskalova, Z. Dvorak, and P. Pavek Endogenous and exogenous ligands of aryl hydrocarbon receptor: current state of art Curr Drug Metab 12 2011 198 212
7. B.K. Meyer, M.G. Pray-Grant, J.P. Vanden Heuvel, and G.H. Perdew Hepatitis B virus X-associated protein 2 is a subunit of the unliganded aryl hydrocarbon receptor core complex and exhibits transcriptional enhancer activity Mol Cell Biol 18 1998 978 988
8. O. Hankinson The aryl hydrocarbon receptor complex Annu Rev Pharmacol Toxicol 35 1995 307 340
9. E. Zudaire, N. Cuesta, V. Murty, K. Woodson, L. Adams, and N. Gonzalez The aryl hydrocarbon receptor repressor is a putative tumor suppressor gene in multiple human cancers J Clin Invest 118 2008 640 650
10. Y. Kanno, S. Otsuka, T. Hiromasa, T. Nakahama, and Y. Inouye Diurnal difference in CAR mRNA expression Nucl Recept 2 2004 6
11. F. Gachon, F.F. Olela, O. Schaad, P. Descombes, and U. Schibler The circadian PAR-domain basic leucine zipper transcription factors DBP, TEF, and HLF modulate basal and inducible xenobiotic detoxification Cell Metab 4 2006 25 36
12. T. Claudel, G. Cretenet, A. Saumet, and F. Gachon Crosstalk between xenobiotics metabolism and circadian clock FEBS Lett 581 2007 3626 3633
13. U.P. Zmrzljak, and D. Rozman Circadian regulation of the hepatic endobiotic and xenobitoic detoxification pathways: the time matters Chem Res Toxicol 25 2012 811 824
14. F. Levi, and U. Schibler Circadian rhythms: mechanisms and therapeutic implications Annu Rev Pharmacol Toxicol 47 2007 593 628
15. C. Wang, C.X. Xu, S.L. Krager, K.M. Bottum, D.F. Liao, and S.A. Tischkau Aryl hydrocarbon receptor deficiency enhances insulin sensitivity and reduces PPAR-alpha pathway activity in mice Environ Health Perspect 119 2011 1739 1744
16. P. Huang, S. Ceccatelli, and A. Rannug A study on diurnal mRNA expression of CYP1A1, AHR, ARNT, and PER2 in rat pituitary and liver Environ Toxicol Pharmacol 11 2002 119 126
17. N. Tanimura, N. Kusunose, N. Matsunaga, S. Koyanagi, and S. Ohdo Aryl hydrocarbon receptor-mediated Cyp1a1 expression is modulated in a CLOCK-dependent circadian manner Toxicology 290 2011 203 207
18. R.W. Garrett, and T.A. Gasiewicz The aryl hydrocarbon receptor agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin alters the circadian rhythms, quiescence, and expression of clock genes in murine hematopoietic stem and progenitor cells Mol Pharmacol 69 2006 2076 2083
19. M. Mukai, T.M. Lin, R.E. Peterson, P.S. Cooke, and S.A. Tischkau Behavioral rhythmicity of mice lacking AhR and attenuation of light-induced phase shift by 2,3,7,8-tetrachlorodibenzo-p-dioxin J Biol Rhythms 23 2008 200 210
20. S.A. Tischkau, C.D. Jaeger, and S.L. Krager Circadian clock disruption in the mouse ovary in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin Toxicol Lett 201 2011 116 122
21. C.X. Xu, S.L. Krager, D.F. Liao, and S.A. Tischkau Disruption of CLOCK-BMAL1 transcriptional activity is responsible for aryl hydrocarbon receptor-mediated regulation of Period1 gene Toxicol Sci 115 2010 98 108
22. J.S. Pendergast, and S. Yamazaki The mammalian circadian system is resistant to dioxin J Biol Rhythms 27 2012 156 163
23. X. Qu, R.P. Metz, W.W. Porter, V.M. Cassone, and D.J. Earnest Disruption of period gene expression alters the inductive effects of dioxin on the AhR signaling pathway in the mouse liver Toxicol Appl Pharmacol 234 2009 370 377
24. X. Qu, R.P. Metz, W.W. Porter, V.M. Cassone, and D.J. Earnest Disruption of clock gene expression alters responses of the aryl hydrocarbon receptor signaling pathway in the mouse mammary gland Mol Pharmacol 72 2007 1349 1358
25. X. Qu, R.P. Metz, W.W. Porter, N. Neuendorff, B.J. Earnest, and D.J. Earnest The clock genes period 1 and period 2 mediate diurnal rhythms in dioxin-induced Cyp1A1 expression in the mouse mammary gland and liver Toxicol Lett 196 2010 28 32
26. T. Takiguchi, M. Tomita, N. Matsunaga, H. Nakagawa, S. Koyanagi, and S. Ohdo Molecular basis for rhythmic expression of CYP3A4 in serum-shocked HepG2 cells Pharmacogenet Genomics 17 2007 1047 1056
27. B. Oesch-Bartlomowicz, and F. Oesch Role of cAMP in mediating AHR signaling Biochem Pharmacol 77 2009 627 641
28. J.S. O'Neill, E.S. Maywood, J.E. Chesham, J.S. Takahashi, and M.H. Hastings cAMP-dependent signaling as a core component of the mammalian circadian pacemaker Science 320 2008 949 953
29. C. Beaule, A. Swanstrom, M.J. Leone, and E.D. Herzog Circadian modulation of gene expression, but not glutamate uptake, in mouse and rat cortical astrocytes PLoS ONE 4 2009 e7476
30. B. Oesch-Bartlomowicz, A. Huelster, O. Wiss, P. Antoniou-Lipfert, C. Dietrich, and M. Arand Aryl hydrocarbon receptor activation by cAMP vs dioxin: divergent signaling pathways Proc Natl Acad Sci USA 102 2005 9218 9223
31. B. Oesch-Bartlomowicz, and F. Oesch Phosphorylation of cytochromes P450: first discovery of a posttranslational modification of a drug-metabolizing enzyme Biochem Biophys Res Commun 338 2005 446 449
32. M. Mukai, and S.A. Tischkau Effects of tryptophan photoproducts in the circadian timing system: searching for a physiological role for aryl hydrocarbon receptor Toxicol Sci 95 2007 172 181
33. R. Sibilano, B. Frossi, M. Calvaruso, L. Danelli, E. Betto, and A. Dall'Agnese The aryl hydrocarbon receptor modulates acute and late mast cell responses J Immunol 189 2012 120 127
34. A. Mayati, N. Levoin, H. Paris, M. N'Diaye, A. Courtois, and P. Uriac Induction of intracellular calcium concentration by environmental benzo(a)pyrene involves a beta2-adrenergic receptor/adenylyl cyclase/Epac-1/inositol 1,4,5-trisphosphate pathway in endothelial cells J Biol Chem 287 2012 4041 4052
35. P. Monteiro, D. Gilot, E. Le Ferrec, C. Rauch, D. Lagadic-Gossmann, and O. Fardel Dioxin-mediated up-regulation of aryl hydrocarbon receptor target genes is dependent on the calcium/calmodulin/CaMKIalpha pathway Mol Pharmacol 73 2008 769 777
36. J. Dai, E.W. Inscho, L. Yuan, and S.M. Hill Modulation of intracellular calcium and calmodulin by melatonin in MCF-7 human breast cancer cells J Pineal Res 32 2002 112 119
37. N. Cermakian, E.W. Lamont, P. Boudreau, and D.B. Boivin Circadian clock gene expression in brain regions of Alzheimer's disease patients and control subjects J Biol Rhythms 26 2011 160 170
38. T.M. Osland, J. Ferno, B. Havik, I. Heuch, P. Ruoff, and O.D. Laerum Lithium differentially affects clock gene expression in serum-shocked NIH-3T3 cells J Psychopharmacol 25 7 2011 924 933 10.1177/0269881110379508
39. G. Anderson, M. Maes, and M. Berk Inflammation-related disorders in the tryptophan catabolite pathway in depression and somatization Adv Protein Chem Struct Biol 88 2012 27 48
40. E. Luchowska, R. Kloc, B. Olajossy, S. Wnuk, M. Wielosz, and B. Owe-Larsson beta-adrenergic enhancement of brain kynurenic acid production mediated via cAMP-related protein kinase A signaling Prog Neuropsychopharmacol Biol Psychiatry 33 2009 519 529
41. C.A. Opitz, U.M. Litzenburger, F. Sahm, M. Ott, I. Tritschler, and S. Trump An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor Nature 478 2011 197 203
42. S.K. de Oliveira, M. Hoffmeister, S. Gambaryan, W. Muller-Esterl, J.A. Guimaraes, and A.P. Smolenski Phosphodiesterase 2A forms a complex with the co-chaperone XAP2 and regulates nuclear translocation of the aryl hydrocarbon receptor J Biol Chem 282 2007 13656 13663
43. A.S. Sierksma, K. Rutten, S. Sydlik, S. Rostamian, H.W. Steinbusch, and D.L. van den Hove Chronic phosphodiesterase type 2 inhibition improves memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease Neuropharmacology 64 2013 124 136
44. M. Fukuda, K.W. Williams, L. Gautron, and J.K. Elmquist Induction of leptin resistance by activation of cAMP-Epac signaling Cell Metab 13 2011 331 339
45. J.S. Kerley-Hamilton, H.W. Trask, C.J. Ridley, E. Dufour, C.S. Ringelberg, and N. Nurinova Obesity is mediated by differential aryl hydrocarbon receptor signaling in mice fed a Western diet Environ Health Perspect 120 2012 1252 1259
46. E.A. Kiss, and C. Vonarbourg Aryl hydrocarbon receptor: a molecular link between postnatal lymphoid follicle formation and diet Gut Microbes 3 2012 577 582
47. F. Tavano, F.F. di Mola, A. Latiano, O. Palmieri, F. Bossa, and M.R. Valvano Neuroimmune interactions in patients with inflammatory bowel diseases: disease activity and clinical behavior based on substance P serum levels J Crohns Colitis 6 2012 563 570
48. J. Zhang, H. Li, H. Teng, T. Zhang, Y. Luo, and M. Zhao Regulation of peripheral clock to oscillation of substance P contributes to circadian inflammatory pain Anesthesiology 117 2012 149 160
49. R. Arsenescu, V. Arsenescu, J. Zhong, M. Nasser, R. Melinte, and R.W. Dingle Role of the xenobiotic receptor in inflammatory bowel disease Inflamm Bowel Dis 17 2012 1149 1162
50. D. Rohlman, D. Pham, Z. Yu, L.B. Steppan, and N.I. Kerkvliet Aryl hydrocarbon receptor-mediated perturbations in gene expression during early stages of CD4(+) T-cell differentiation Front Immunol 3 2012 223
51. J.M. Benson, and D.M. Shepherd Aryl hydrocarbon receptor activation by TCDD reduces inflammation associated with Crohn's disease Toxicol Sci 120 2011 68 78
52. N.P. Singh, U.P. Singh, B. Singh, R.L. Price, M. Nagarkatti, and P.S. Nagarkatti Activation of aryl hydrocarbon receptor (AhR) leads to reciprocal epigenetic regulation of FoxP3 and IL-17 expression and amelioration of experimental colitis PLoS ONE 6 2011 e23522
53. I. Monteleone, T.T. MacDonald, F. Pallone, and G. Monteleone The aryl hydrocarbon receptor in inflammatory bowel disease: linking the environment to disease pathogenesis Curr Opin Gastroenterol 28 2012 310 313
54. C.W. Wells, S. Lewis, J.R. Barton, and S. Corbett Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients Inflamm Bowel Dis 12 2006 123 130
55. S.E. Lakhan, and A. Kirchgessner Anti-inflammatory effects of nicotine in obesity and ulcerative colitis J Transl Med 9 2011 129
56. G.R. Swanson, H.J. Burgess, and A. Keshavarzian Sleep disturbances and inflammatory bowel disease: a potential trigger for disease flare Expert Rev Clin Immunol 7 2011 29 36
57. L. Zhou, H. Chen, Q. Wen, and Y. Zhang Indoleamine 2,3-dioxygenase expression in human inflammatory bowel disease Eur J Gastroenterol Hepatol 24 2012 695 701
58. N.K. Gupta, A.I. Thaker, N. Kanuri, T.E. Riehl, C.W. Rowley, and W.F. Stenson Serum analysis of tryptophan catabolism pathway: correlation with Crohn's disease activity Inflamm Bowel Dis 18 2012 1214 1220
59. S.S. Yarandi, G. Hebbar, C.G. Sauer, C.R. Cole, and T.R. Ziegler Diverse roles of leptin in the gastrointestinal tract: modulation of motility, absorption, growth, and inflammation Nutrition 27 2011 269 275
60. G. Lakatos, I. Hritz, M.Z. Varga, M. Juhasz, P. Miheller, and G. Cierny The impact of matrix metalloproteinases and their tissue inhibitors in inflammatory bowel diseases Dig Dis 30 2012 289 295
61. T. Kung, K.A. Murphy, and L.A. White The aryl hydrocarbon receptor (AhR) pathway as a regulatory pathway for cell adhesion and matrix metabolism Biochem Pharmacol 77 2009 536 546
62. A. Cesaro, A. Abakar-Mahamat, P. Brest, S. Lassalle, E. Selva, and J. Filippi Differential expression and regulation of ADAM17 and TIMP3 in acute inflamed intestinal epithelia Am J Physiol Gastrointest Liver Physiol 296 2009 G1332 G1343
63. L.Q. Ge, T. Jiang, J. Zhao, Z.T. Chen, F. Zhou, and B. Xia Upregulated mRNA expression of major histocompatibility complex class I chain-related gene A in colon and activated natural killer cells of Chinese patients with ulcerative colitis J Dig Dis 12 2011 82 89
64. S. Aguera-Gonzalez, C.C. Gross, L. Fernandez-Messina, O. Ashiru, G. Esteso, and H.C. Hang Palmitoylation of MICA, a ligand for NKG2D, mediates its recruitment to membrane microdomains and promotes its shedding Eur J Immunol 41 2011 3667 3676
65. R. Lopez-Hernandez, M. Valdes, D. Lucas, J.A. Campillo, P. Martinez-Garcia, and H. Salama Association analysis of MICA gene polymorphism and MICA-129 dimorphism with inflammatory bowel disease susceptibility in a Spanish population Hum Immunol 71 2010 512 514
66. T. Simones, and D.M. Shepherd Consequences of AhR activation in steady-state dendritic cells Toxicol Sci 119 2011 293 307
67. M.R. Zocchi, S. Catellani, P. Canevali, S. Tavella, A. Garuti, and B. Villaggio High ERp5/ADAM10 expression in lymph node microenvironment and impaired NKG2D ligands recognition in Hodgkin lymphomas Blood 119 2012 1479 1489
68. Y. Kurashima, T. Amiya, T. Nochi, K. Fujisawa, T. Haraguchi, and H. Iba Extracellular ATP mediates mast cell-dependent intestinal inflammation through P2X7 purinoceptors Nat Commun 3 2012 1034
69. Y. Nakamura, D. Harama, N. Shimokawa, M. Hara, R. Suzuki, and Y. Tahara Circadian clock gene Period2 regulates a time-of-day-dependent variation in cutaneous anaphylactic reaction J Allergy Clin Immunol 127 2011 1038 1045 e1-3
70. T.C. Theoharides, B. Zhang, D. Kempuraj, M. Tagen, M. Vasiadi, and A. Angelidou IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin Proc Natl Acad Sci USA 107 2010 4448 4453
71. V. Motilva, S. Garcia-Maurino, E. Talero, and M. Illanes New paradigms in chronic intestinal inflammation and colon cancer: role of melatonin J Pineal Res 51 2011 44 60
72. C. Chojnacki, M. Wisniewska-Jarosinska, E. Walecka-Kapica, G. Klupinska, J. Jaworek, and J. Chojnacki Evaluation of melatonin effectiveness in the adjuvant treatment of ulcerative colitis J Physiol Pharmacol 62 2011 327 334
73. M. Chen, Q. Mei, J. Xu, C. Lu, H. Fang, and X. Liu Detection of melatonin and homocysteine simultaneously in ulcerative colitis Clin Chim Acta 413 2012 30 33
74. C.Q. Chen, J. Fichna, M. Bashashati, Y.Y. Li, and M. Storr Distribution, function and physiological role of melatonin in the lower gut World J Gastroenterol 17 2011 3888 3898
75. M. Tajes, J. Gutierrez-Cuesta, D. Ortuno-Sahagun, A. Camins, and M. Pallas Anti-aging properties of melatonin in an in vitro murine senescence model: involvement of the sirtuin 1 pathway J Pineal Res 47 2009 228 237
76. T.K. Chang, J. Chen, G. Yang, and E.Y. Yeung Inhibition of procarcinogen-bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin J Pineal Res 48 2010 55 64
77. R. Glauben, A. Batra, I. Fedke, M. Zeitz, H.A. Lehr, and F. Leoni Histone hyperacetylation is associated with amelioration of experimental colitis in mice J Immunol 176 2006 5015 5022
78. K. Yamanegi, J. Yamane, K. Kobayashi, H. Ohyama, K. Nakasho, and N. Yamada Downregulation of matrix metalloproteinase-9 mRNA by valproic acid plays a role in inhibiting the shedding of MHC class I-related molecules A and B on the surface of human osteosarcoma cells Oncol Rep 28 2012 1585 1590
79. A. Jussila, L.J. Virta, V. Salomaa, J. Maki, A. Jula, and M.A. Farkkila High and increasing prevalence of inflammatory bowel disease in Finland with a clear North-South difference J Crohns Colitis 2012 10.1016/j.crohns.2012.10.007
80. H. Zhao, H. Zhang, H. Wu, H. Li, L. Liu, and J. Guo Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice BMC Gastroenterol 12 2012 57
81. L.N. Xue, K.Q. Xu, W. Zhang, Q. Wang, J. Wu, and X.Y. Wang Associations between vitamin D receptor polymorphisms and susceptibility to ulcerative Colitis and Crohn's disease: a meta-analysis Inflamm Bowel Dis 19 2012 54 60
82. L.M. Castro, M. Gallant, and L.P. Niles Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells J Neurochem 95 2005 1227 1236
83. R.J. Dempsey, and W.F. Chandler Abnormal serum melatonin levels in patients with intrasellar tumors Neurosurgery 15 1984 815 819
84. T. Tynes, M. Hannevik, A. Andersen, A.I. Vistnes, and T. Haldorsen Incidence of breast cancer in Norwegian female radio and telegraph operators Cancer Causes Control 7 1996 197 204
85. J. Hansen, and C.F. Lassen Nested case-control study of night shift work and breast cancer risk among women in the Danish military Occup Environ Med 69 2012 551 556
86. J.A. Lie, H. Kjuus, S. Zienolddiny, A. Haugen, R.G. Stevens, and K. Kjaerheim Night work and breast cancer risk among Norwegian nurses: assessment by different exposure metrics Am J Epidemiol 173 2011 1272 1279
87. F. Menegaux, T. Truong, A. Anger, E. Cordina-Duverger, F. Lamkarkach, and P. Arveux Night work and breast cancer: a population-based case-control study in France (the CECILE study) Int J Cancer 132 4 2012 924 931 10.1002/ijc.27669
88. B. Pesch, V. Harth, S. Rabstein, C. Baisch, M. Schiffermann, and D. Pallapies Night work and breast cancer-results from the German GENICA study Scand J Work Environ Health 36 2010 134 141
89. C. Yi, L. Mu, I.A. de la Longrais, O. Sochirca, R. Arisio, and H. Yu The circadian gene NPAS2 is a novel prognostic biomarker for breast cancer Breast Cancer Res Treat 120 2010 663 669
90. T. Kubo, K. Ozasa, K. Mikami, K. Wakai, Y. Fujino, and Y. Watanabe Prospective cohort study of the risk of prostate cancer among rotating-shift workers: findings from the Japan collaborative cohort study Am J Epidemiol 164 2006 549 555
91. E.S. Schernhammer, F. Laden, F.E. Speizer, W.C. Willett, D.J. Hunter, and I. Kawachi Night-shift work and risk of colorectal cancer in the nurses' health study J Natl Cancer Inst 95 2003 825 828
92. X.S. Wang, M.E. Armstrong, B.J. Cairns, T.J. Key, and R.C. Travis Shift work and chronic disease: the epidemiological evidence Occup Med (Lond) 61 2011 78 89
93. T.A. Lahti, T. Partonen, P. Kyyronen, T. Kauppinen, and E. Pukkala Night-time work predisposes to non-Hodgkin lymphoma Int J Cancer 123 2008 2148 2151
94. A.E. Hoffman, T. Zheng, R.G. Stevens, Y. Ba, Y. Zhang, and D. Leaderer Clock-cancer connection in non-Hodgkin's lymphoma: a genetic association study and pathway analysis of the circadian gene cryptochrome 2 Cancer Res 69 2009 3605 3613
95. Y. Zhu, D. Leaderer, C. Guss, H.N. Brown, Y. Zhang, and P. Boyle Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma Int J Cancer 120 2007 432 435
96. L. Eisele, R. Prinz, L. Klein-Hitpass, H. Nuckel, K. Lowinski, and J. Thomale Combined PER2 and CRY1 expression predicts outcome in chronic lymphocytic leukemia Eur J Haematol 83 2009 320 327
97. S. Gery, and H.P. Koeffler Per2 is a C/EBP target gene implicated in myeloid leukemia Integr Cancer Ther 8 2009 317 320
98. H. Taniguchi, A.F. Fernandez, F. Setien, S. Ropero, E. Ballestar, and A. Villanueva Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies Cancer Res 69 2009 8447 8454
99. M. Krawczak, and D.N. Cooper p53 mutations, benzo[a]pyrene and lung cancer Mutagenesis 13 1998 319 320
100. V.N. Giri, A.E. Cassidy, J. Beebe-Dimmer, L.R. Ellis, D.C. Smith, and C.H. Bock Association between Agent Orange and prostate cancer: a pilot case-control study Urology 63 2004 757 760 [discussion 60-1]
101. M. Pavuk, J.E. Michalek, A. Schecter, N.S. Ketchum, F.Z. Akhtar, and K.A. Fox Did TCDD exposure or service in Southeast Asia increase the risk of cancer in air force Vietnam veterans who did not spray agent orange J Occup Environ Med 47 2005 335 342
102. M.B. Zafar, and M.K. Terris Prostate cancer detection in veterans with a history of Agent Orange exposure J Urol 166 2001 100 103
103. P.A. Bertazzi, C. Zocchetti, A.C. Pesatori, S. Guercilena, M. Sanarico, and L. Radice Ten-year mortality study of the population involved in the Seveso incident in 1976 Am J Epidemiol 129 1989 1187 1200
104. A.E. Hoffman, T. Zheng, C.H. Yi, R.G. Stevens, Y. Ba, and Y. Zhang The core circadian gene Cryptochrome 2 influences breast cancer risk, possibly by mediating hormone signaling Cancer Prev Res (Phila) 3 2010 539 548
105. L. Fu, H. Pelicano, J. Liu, P. Huang, and C. Lee The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo Cell 111 2002 41 50
106. N.H. Thoennissen, G.B. Thoennissen, S. Abbassi, S. Nabavi-Nouis, T. Sauer, and N.B. Doan Transcription factor CCAAT/enhancer-binding protein alpha and critical circadian clock downstream target gene PER2 are highly deregulated in diffuse large B-cell lymphoma Leuk Lymphoma 53 2012 1577 1585
107. S. Gery, A.F. Gombart, W.S. Yi, C. Koeffler, W.K. Hofmann, and H.P. Koeffler Transcription profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemia Blood 106 2005 2827 2836
108. Z. Yu, C.V. Loehr, K.A. Fischer, M.A. Louderback, S.K. Krueger, and R.H. Dashwood In utero exposure of mice to dibenzo[a,l]pyrene produces lymphoma in the offspring: role of the aryl hydrocarbon receptor Cancer Res 66 2006 755 762
109. C.H. Ng, R. Janoo-Gilani, P. Sipahimalani, R.P. Gallagher, R.D. Gascoyne, and J.M. Connors Interaction between organochlorines and the AHR gene, and risk of non-Hodgkin lymphoma Cancer Causes Control 21 2010 11 22
110. C.F. Vogel, W. Li, E. Sciullo, J. Newman, B. Hammock, and J.R. Reader Pathogenesis of aryl hydrocarbon receptor-mediated development of lymphoma is associated with increased cyclooxygenase-2 expression Am J Pathol 171 2007 1538 1548
111. S. Mulero-Navarro, J.M. Carvajal-Gonzalez, M. Herranz, E. Ballestar, M.F. Fraga, and S. Ropero The dioxin receptor is silenced by promoter hypermethylation in human acute lymphoblastic leukemia through inhibition of Sp1 binding Carcinogenesis 27 2006 1099 1104
112. J.E. Rager, and R.C. Fry The aryl hydrocarbon receptor pathway: a key component of the microRNA-mediated AML signalisome Int J Environ Res Public Health 9 2012 1939 1953
113. A. Enjuanes, V. Fernandez, L. Hernandez, A. Navarro, S. Bea, and M. Pinyol Identification of methylated genes associated with aggressive clinicopathological features in mantle cell lymphoma PLoS ONE 6 2011 e19736
114. B. Wang, and S.F. Zhou Synthetic and natural compounds that interact with human cytochrome P450 1A2 and implications in drug development Curr Med Chem 16 2009 4066 4218
115. S. Xiang, L. Mao, T. Duplessis, L. Yuan, R. Dauchy, and E. Dauchy Oscillation of clock and clock controlled genes induced by serum shock in human breast epithelial and breast cancer cells: regulation by melatonin Breast Cancer 6 2012 137 150
116. S. Takahata, K. Sogawa, A. Kobayashi, M. Ema, J. Mimura, and N. Ozaki Transcriptionally active heterodimer formation of an Arnt-like PAS protein, Arnt3, with HIF-1a, HLF, and clock Biochem Biophys Res Commun 248 1998 789 794
117. J.B. Hogenesch, Y.Z. Gu, S. Jain, and C.A. Bradfield The basic-helix-loop-helix-PAS orphan MOP3 forms transcriptionally active complexes with circadian and hypoxia factors Proc Natl Acad Sci USA 95 1998 5474 5479
118. H. Hosoda, K. Kato, H. Asano, M. Ito, H. Kato, and T. Iwamoto CBP/p300 is a cell type-specific modulator of CLOCK/BMAL1-mediated transcription Mol Brain 2 2009 34
119. H.C. Hung, C. Maurer, S.A. Kay, and F. Weber Circadian transcription depends on limiting amounts of the transcription co-activator nejire/CBP J Biol Chem 282 2007 31349 31357
120. A. Kobayashi, K. Numayama-Tsuruta, K. Sogawa, and Y. Fujii-Kuriyama CBP/p300 functions as a possible transcriptional coactivator of Ah receptor nuclear translocator (Arnt) J Biochem 122 1997 703 710
121. S. Takahata, T. Ozaki, J. Mimura, Y. Kikuchi, K. Sogawa, and Y. Fujii-Kuriyama Transactivation mechanisms of mouse clock transcription factors, mClock and mArnt3 Genes Cells 5 2000 739 747
122. S.R. Beedanagari, R.T. Taylor, P. Bui, F. Wang, D.W. Nickerson, and O. Hankinson Role of epigenetic mechanisms in differential regulation of the dioxin-inducible human CYP1A1 and CYP1B1 genes Mol Pharmacol 78 2010 608 616
123. A.M. Curtis, S.B. Seo, E.J. Westgate, R.D. Rudic, E.M. Smyth, and D. Chakravarti Histone acetyltransferase-dependent chromatin remodeling and the vascular clock J Biol Chem 279 2004 7091 7097
124. T.V. Beischlag, S. Wang, D.W. Rose, J. Torchia, S. Reisz-Porszasz, and K. Muhammad Recruitment of the NCoA/SRC-1/p160 family of transcriptional coactivators by the aryl hydrocarbon receptor/aryl hydrocarbon receptor nuclear translocator complex Mol Cell Biol 22 2002 4319 4333
125. M.B. Kumar, and G.H. Perdew Nuclear receptor coactivator SRC-1 interacts with the Q-rich subdomain of the AhR and modulates its transactivation potential Gene Expr 8 1999 273 286
126. T.V. Beischlag, J. Luis Morales, B.D. Hollingshead, and G.H. Perdew The aryl hydrocarbon receptor complex and the control of gene expression Crit Rev Eukaryot Gene Expr 18 2008 207 250
127. M.P. Labrecque, G.G. Prefontaine, and T.V. Beischlag The aryl hydrocarbon receptor nuclear translocator (ARNT) family of proteins: transcriptional modifiers with multi-functional protein interfaces Curr Mol Med 2012 PMID:23116263 [Epub ahead of print]
128. T.V. Beischlag, and G.H. Perdew ER alpha-AHR-ARNT protein-protein interactions mediate estradiol-dependent transrepression of dioxin-inducible gene transcription J Biol Chem 280 2005 21607 21611
129. B.D. Hollingshead, T.V. Beischlag, B.C. Dinatale, P. Ramadoss, and G.H. Perdew Inflammatory signaling and aryl hydrocarbon receptor mediate synergistic induction of interleukin 6 in MCF-7 cells Cancer Res 68 2008 3609 3617
130. M.P. Labrecque, M.K. Takhar, B.D. Hollingshead, G.G. Prefontaine, G.H. Perdew, and T.V. Beischlag Distinct roles for aryl hydrocarbon receptor nuclear translocator and ah receptor in estrogen-mediated signaling in human cancer cell lines PLoS ONE 7 2012 e29545
131. J. Matthews, B. Wihlen, J. Thomsen, and J.A. Gustafsson Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor {alpha} to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters Mol Cell Biol 25 2005 5317 5328
132. F. Ohtake, K. Takeyama, T. Matsumoto, H. Kitagawa, Y. Yamamoto, and K. Nohara Modulation of oestrogen receptor signalling by association with the activated dioxin receptor Nature 423 2003 545 550
133. S. Li, M. Wang, X. Ao, A.K. Chang, C. Yang, and F. Zhao CLOCK is a substrate of SUMO and sumoylation of CLOCK upregulates the transcriptional activity of estrogen receptor-alpha Oncogene 2012 10.1038/onc.2012.518 [Epub ahead of print]
134. F. Ohtake, Y. Fujii-Kuriyama, K. Kawajiri, and S. Kato Cross-talk of dioxin and estrogen receptor signals through the ubiquitin system J Steroid Biochem Mol Biol 127 2011 102 107
135. E. Swedenborg, and I. Pongratz AhR and ARNT modulate ER signaling Toxicology 268 2010 132 138
136. J. Ruegg, E. Swedenborg, D. Wahlstrom, A. Escande, P. Balaguer, and K. Pettersson The transcription factor aryl hydrocarbon receptor nuclear translocator functions as an estrogen receptor beta-selective coactivator, and its recruitment to alternative pathways mediates antiestrogenic effects of dioxin Mol Endocrinol 22 2008 304 316
137. R. Narasimamurthy, M. Hatori, S.K. Nayak, F. Liu, S. Panda, and I.M. Verma Circadian clock protein cryptochrome regulates the expression of proinflammatory cytokines Proc Natl Acad Sci USA 109 2012 12662 12667
138. Y. Tian, S. Ke, M.S. Denison, A.B. Rabson, and M.A. Gallo Ah receptor and NF-kappaB interactions, a potential mechanism for dioxin toxicity J Biol Chem 274 1999 510 515
139. Y. Tian, A.B. Rabson, and M.A. Gallo Ah receptor and NF-kappaB interactions: mechanisms and physiological implications Chem Biol Interact 141 2002 97 115
140. D.W. Kim, L. Gazourian, S.A. Quadri, R. Romieu-Mourez, D.H. Sherr, and G.E. Sonenshein The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells Oncogene 19 2000 5498 5506
141. M.M. Bellet, L. Zocchi, and P. Sassone-Corsi The RelB subunit of NFkappaB acts as a negative regulator of circadian gene expression Cell cycle 11 2012 3304 3311
142. C.F. Vogel, W. Li, D. Wu, J.K. Miller, C. Sweeney, and G. Lazennec Interaction of aryl hydrocarbon receptor and NF-kappaB subunit RelB in breast cancer is associated with interleukin-8 overexpression Arch Biochem Biophys 512 2011 78 86
143. J. Borjigin, L.S. Zhang, and A.A. Calinescu Circadian regulation of pineal gland rhythmicity Mol Cell Endocrinol 349 1 2012 13 19
144. R. Hardeland, J.A. Madrid, D.X. Tan, and R.J. Reiter Melatonin, the circadian multioscillator system and health: the need for detailed analyses of peripheral melatonin signaling J Pineal Res 52 March (2) 2012 139 166
145. C. Bartsch, H. Bartsch, A. Schmidt, S. Ilg, K.H. Bichler, and S.H. Flüchter Melatonin and 6-sulfatoxymelatonin circadian rhythms in serum and urine of primary prostate cancer patients: evidence for reduced pineal activity and relevance of urinary determinations Clin Chim Acta 209 3 1992 153 167
146. E.S. Schernhammer, and S.E. Hankinson Urinary melatonin levels and postmenopausal breast cancer risk in the Nurses' Health Study cohort Cancer Epidemiol Biomarkers Prev 18 1 2009 74 79
147. D.N. Danforth Jr., L. Tamarkin, J.J. Mulvihill, C.S. Bagley, and M.E. Lippman Plasma melatonin and the hormone-dependency of human breast cancer J Clin Oncol 3 7 1985 941 948
148. S. Proietti, A. Cucina, F. D'Anselmi, S. Dinicola, A. Pasqualato, and E. Lisi Melatonin and vitamin D3 synergistically down-regulate Akt and MDM2 leading to TGFβ-1-dependent growth inhibition of breast cancer cells J Pineal Res 50 2 2011 150 158
149. B. Jung-Hynes, T.L. Schmit, S.R. Reagan-Shaw, I.A. Siddiqui, H. Mukhtar, and N. Ahmad Melatonin, a novel Sirt1 inhibitor, imparts antiproliferative effects against prostate cancer in vitro in culture and in vivo in TRAMP model J Pineal Res 50 March (2) 2011 140 149
150. D.J. Skene, E. Papagiannidou, E. Hashemi, J. Snelling, D.F. Lewis, and M. Fernandez Contribution of CYP1A2 in the hepatic metabolism of melatonin: studies with isolated microsomal preparations and liver slices J Pineal Res 31 4 2001 333 342